TW200505468A - Agent for improving hepato-bililary dysfunction - Google Patents

Agent for improving hepato-bililary dysfunction

Info

Publication number
TW200505468A
TW200505468A TW093123769A TW93123769A TW200505468A TW 200505468 A TW200505468 A TW 200505468A TW 093123769 A TW093123769 A TW 093123769A TW 93123769 A TW93123769 A TW 93123769A TW 200505468 A TW200505468 A TW 200505468A
Authority
TW
Taiwan
Prior art keywords
bililary
hepato
improving
agent
dysfunction
Prior art date
Application number
TW093123769A
Other languages
English (en)
Inventor
Keiichi Abe
Taeko Iino
Takeshi Kurihara
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of TW200505468A publication Critical patent/TW200505468A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
TW093123769A 2003-08-11 2004-08-09 Agent for improving hepato-bililary dysfunction TW200505468A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003291779 2003-08-11
JP2004146961 2004-05-17

Publications (1)

Publication Number Publication Date
TW200505468A true TW200505468A (en) 2005-02-16

Family

ID=34137956

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093123769A TW200505468A (en) 2003-08-11 2004-08-09 Agent for improving hepato-bililary dysfunction

Country Status (3)

Country Link
JP (1) JPWO2005013970A1 (zh)
TW (1) TW200505468A (zh)
WO (1) WO2005013970A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006232752A (ja) * 2005-02-25 2006-09-07 Tokyo Univ Of Marine Science & Technology コレステロール及び中性脂肪吸収抑制剤及びこれを含む食品
CN103442709B (zh) * 2011-03-22 2018-10-19 财团法人工业技术研究院 减缓肝癌恶化、改善肝功能、改善肝纤维化、改善肝硬化、改善肝发炎及促进受损肝脏再生之药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01
JPH09291039A (ja) * 1995-12-26 1997-11-11 Suntory Ltd プロシアニジンを有効成分とする抗肥満剤
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
JP2975997B2 (ja) * 1998-03-04 1999-11-10 工業技術院長 プロアントシアニジンａおよびその誘導体
EP1072265A1 (en) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols for treating iron overload
JP2003095964A (ja) * 2001-09-21 2003-04-03 Toyo Shinyaku:Kk 抗ストレス剤
JP2004123707A (ja) * 2002-07-29 2004-04-22 Toyo Shinyaku:Kk 血流改善組成物
JP4499371B2 (ja) * 2003-01-14 2010-07-07 株式会社 エフェクト 落花生由来のプロアントシアニジンの製造方法

Also Published As

Publication number Publication date
JPWO2005013970A1 (ja) 2007-09-27
WO2005013970A1 (ja) 2005-02-17

Similar Documents

Publication Publication Date Title
TW200420573A (en) Bifunctional heterocyclic compounds and methods of making and using same
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
WO2004064769A3 (en) Methods for making and using topical delivery agents
TW200621160A (en) Anti-termite agent
WO2007067506A3 (en) 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
TW200800967A (en) Benzimidazole thiophene compounds
MXPA05013553A (es) Pirrolodihidroisoquinolinas como inhibidores de pde10.
DE602004021472D1 (en) Pyrimiidinverbindungen
AU3652102A (en) Compounds and their uses
MXPA05007926A (es) Composiciones herbicidas que contienen aceite de clavo.
MXPA04008772A (es) Composiciones de clorhidrato de naltrexona.
MY135233A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
AU2003228770A8 (en) Substituted pyrazolopyrimidines
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
WO2007013666A3 (en) Anti-tumor agents comprising r-spondins
WO2004014893A3 (en) Antimicrobial aza-bicyclic derivates, their compositions and uses
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MX2007002383A (es) Composiciones que contienen componentes agonistas alfa-2-adrenergicos.
ZA200604874B (en) Pharmaceutical compositions
EP1608395A4 (en) ANTICROPE WITH LK8 PROTEIN AS AN ACTIVE SUBSTANCE